Holen Sie sich die Stockscreener-App
0.3739
0.29%
-0.0011
Handel nachbörslich:
.37
-0.0039
-1.04%
Schlusskurs vom Vortag:
$0.375
Offen:
$0.3734
24-Stunden-Volumen:
321.86K
Relative Volume:
0.05
Marktkapitalisierung:
$5.54M
Einnahmen:
$200.00K
Nettoeinkommen (Verlust:
$-10.95M
KGV:
-0.1894
EPS:
-1.9738
Netto-Cashflow:
$-10.78M
1W Leistung:
+0.70%
1M Leistung:
-5.58%
6M Leistung:
-70.09%
1J Leistung:
-87.24%
1-Tages-Spanne:
$0.3631
$0.395
1-Wochen-Bereich:
$0.3506
$0.395
52-Wochen-Spanne:
$0.28
$6.2299
Soligenix Inc Stock (SNGX) Company Profile
Firmenname
Soligenix Inc
Sektor
Branche
Telefon
609-538-8200
Adresse
29 EMMONS DRIVE, PRINCETON
Compare SNGX vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNGX
Soligenix Inc
|
0.3739 | 5.36M | 200.00K | -10.95M | -10.78M | -1.9738 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Soligenix Inc Stock (SNGX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-07-28 | Herabstufung | Dawson James | Buy → Neutral |
| 2018-01-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2017-08-14 | Bestätigt | Maxim Group | Buy |
| 2017-07-17 | Eingeleitet | H.C. Wainwright | Buy |
Soligenix Inc Aktie (SNGX) Neueste Nachrichten
Soligenix Inc (SNGX) Cash Flow - TradingKey
Soligenix Inc (SNGX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Soligenix Inc (SNGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Soligenix Inc (SNGX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Soligenix Inc (SNGX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Soligenix Inc (SNGX) Institutional Confidence - TradingKey
Soligenix Inc (SNGX) Income Statement - TradingKey
SNGX|Soligenix Inc|Price:0.371|Chg%:-0.002 - TradingKey
Soligenix, Inc. Revenue Breakdown – NASDAQ:SNGX - TradingView
Soligenix (SNGX) seeks reverse stock split and higher authorized shares - Stock Titan
Soligenix (SNGX) Q1 2026 Earnings: Narrower-than-expected net loss per share amid steady pipeline advancement - dars.gov.et
SNGX News | SOLIGENIX INC (NASDAQ:SNGX) - ChartMill
Soligenix (SNGX) seeks reverse stock split, higher share authorization to protect Nasdaq listing - Stock Titan
Soligenix Inc. (SNGX) Q1 2026 Earnings: Narrower-Than-Expected Loss Amid Continued Pipeline Progress - dars.gov.et
Soligenix (SNGX) Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Development ContinuesAnnual Earnings Summary - dars.gov.et
SNGX Stock Price, Quote & Chart - ChartMill
Soligenix Q1 2026 Earnings: Narrower-than-Expected Loss Reflects Cost ManagementAnalyst Drop Coverage - dars.gov.et
Soligenix (SNGX) Q1 2026 Earnings: Small EPS Beat Amid Continued Pipeline ProgressEstimate Dispersion - dars.gov.et
Soligenix, Inc. Financial Disclosures & SEC Filings - TradingView
Soligenix Expands At-the-Market Equity Offering Capacity - The Globe and Mail
SNGX Stock Slumps To Record Low After Lymphoma Trial Fails – All Eyes Now On Behçet’s Disease Treatment - Stocktwits
Form 424B5 Soligenix Inc For: 26 June - Investing.com UK
Form 424B5 Soligenix Inc For: 26 June By Investing.com - Investing.com Nigeria
Soligenix ups ATM offering by $2.5M under Rodman & Renshaw agreement - TradingView
Soligenix (NASDAQ: SNGX) adds $2.5M to at-the-market stock program - Stock Titan
Soligenix (NASDAQ: SNGX) resets ATM capacity to $2.5M under S-3 - Stock Titan
Michael Liu, MJL Manager (SNGX) disclose 983,588 shares; related group holds material blocks - Stock Titan
Soligenix, Inc. Actuals & Estimates (NASDAQ:SNGX) - TradingView
SNGX Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Soligenix, Inc. – NASDAQ:SNGX - TradingView
Price to earnings forward of Soligenix, Inc. – NASDAQ:SNGX - TradingView
SNGX Stock More Than Doubles In Pre-Market, Eyes $1 Breakout For First Time In A Month On Ebola Vaccine Optimism - Stocktwits
Soligenix (SNGX) Slips 2.31% as Stock Nears Key Support at $0.36Ichimoku Entry - po-news-eg.net
Soligenix Q1 2026 Earnings: Narrower Loss Beats Expectations, No Revenue ReportedBasic EPS Analysis - DonanımHaber
Soligenix Inc (SNGX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Soligenix (SNGX) stock soars 72% on ThermoVax platform promise amid Ebola outbreak caused by Bundibugyo virus - MSN
Soligenix Inc. (SNGX) Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesTax Rate Impact - newsline.com
Soligenix Inc (SNGX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Soligenix Inc (SNGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Soligenix Inc (SNGX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SNGX Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Stock ReactionEstimate Revision Count - dars.gov.et
Soligenix Q1 2026 Earnings: Narrower-Than-Expected Loss as EPS Beats EstimatesRevenue Breakdown Analysis - newsline.com
Soligenix (SNGX) Hovers Near Key Support After Modest DeclineBearish Pattern Stocks - newsline.com
Soligenix Halts HyBryte Program, Refocuses Pipeline Strategy - TipRanks
Soligenix's Richard C. Straube ceases Consulting CMO role; duties moved to Christopher Pullion - TradingView
Soligenix (NASDAQ: SNGX) faces Nasdaq bid-price risk and ends HyBryte program - Stock Titan
SNGX Q1 2026 Earnings: EPS Beat Amid No Revenue, Stock DeclinesGross Profit Margin - newsline.com
Soligenix Received Notice of Noncompliance - TradingView
Soligenix (SNGX) Bounces From Support: Biotech Stock Rises 3.5% to $0.44IV Contraction - newsline.com
Soligenix Stock Short Interest Rises to 43.99% - Quiver Quantitative
Soligenix(SNGX) Stock Options Chain | Quotes & News - Moomoo
Finanzdaten der Soligenix Inc-Aktie (SNGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.44%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):